Why we are looking forward to SGO 2017: Breakthroughs in treating gynecologic cancer including Cesium-131 Permanent Interstitial Brachytherapy (PIB)

Isoray is excited to be supporting the upcoming Society of Gynecologic Oncology (SGO) annual meeting, which will be held March 12-15 in National Harbor, Maryland. The SGO meeting serves as a forum on women’s cancer, providing the latest clinical updates and research...
Read More

Pioneer in Prostate Cancer Treatment Leads Data-Driven Approach to Conquer Disease

With over 6000 prostate cancer brachytherapy procedures to date and thousands of IMRT patients, Dr. John Sylvester is a leading authority on research to combat this deadly disease. He recently shared his thoughts on the most effective treatment combinations, and...
Read More

University of Kentucky Radiation Oncologists Use Brachytherapy to Lead the Fight Against Gynecologic Cancer

Dr. Marcus Randall and Dr. Jonathan Feddock have a decades-long history in fighting cervix and vaginal cancer and have a unique specialization in recurrent cancers and re-irradiation treatments. Both are strong believers in interstitial brachytherapy and permanent...
Read More

Leading Prostate Cancer Expert Delivers Insight on Most Effective Treatment

With over thirty years of experience treating prostate cancer expert and pioneer Dr. David Schreiber shares his opinion on his preferred treatment—Brachytherapy—and how this radioactive seed implant technology combined with the latest isotope, Cesium-131, has resulted...
Read More

4 Options—1 Choice: Advice from a Prostate Cancer Pioneer on Navigating Treatment

Dr. Steven Kurtzman, a pioneer in Brachytherapy treatment, shared his insights here on what he feels is the best path forward in charting a path towards successful prostate cancer treatment. With a career-long focus on combating this deadly disease, Dr. Kurtzman...
Read More

Recent News

Bringing Compassion and Hope to Cancer Patients

The following article originally appeared in the Winter/Spring 2017 MicroCap Review Magazine. A small company in Richland, WA is dedicated to making a difference in the lives of patients diagnosed with different forms of cancer. Isoray Medical, Inc. [NYSE MKT:ISR] has...

Cs-131 is a favorable isotope for use across a wide range of tumors and its dose distribution properties facilitate easy calculation and use in the clinic. Dr. Voichita Bar-Ad

Thomas Jefferson University Hospital

Find A Cesium Pioneer Near You

Doctors going above and beyond against the fight with cancer. Learn More

All News

Bringing Compassion and Hope to Cancer Patients

The following article originally appeared in the Winter/Spring 2017 MicroCap Review Magazine. A small company in Richland, WA is dedicated to making a difference in the lives of patients diagnosed with different forms of cancer. Isoray Medical, Inc. [NYSE MKT:ISR] has...

Women’s Cancer and Cesium-131 Treatments

Topic of Two Presentations at the 2016 Annual Meeting of the American Brachytherapy Society and World Congress of Brachytherapy RICHLAND, Wash., July 6, 2016 /PRNewswire/ — IsoRay Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy...

IsoRay Appoints Thomas LaVoy as CEO

Richland, WA January 14, 2016 – IsoRay Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced the...